Surgery for early and minimally invasive breast cancer

Current Opinion in Oncology

Volumn 8, Issue 6, 1996, Pages 468-477

  Graves, Theresa A ^a   Bland, Kirby I ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER INVASION; CANCER SCREENING; CLINICAL PROTOCOL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EARLY CANCER; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEREOTAXIC SURGERY;

EID: 0029903780     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-199611000-00005     Document Type: Review

References (43)

1. Doyle AJ, Murray KA, Nelson EW, Bragg DG: Selective use of imageguided large-core needle biopsy of the breast: Accuracy and cost-effectiveness. Am J Roentgenol 1995, 165:281-284.
2. Liberman L, Fahs MC, Dershaw DD, Bonaccio E, Abramson AF, Cohen MA, Hann LE: Impact of stereotactic core breast biopsy on cost of diagnosis. Radiology 1995, 195:633-637. An analysis of the cost-effectiveness of stereotaxic core breast biopsy, which was evaluated by determining the ability of core biopsy to replace the surgical procedure.
3. Rubin E, Dempsey PJ, Pile NS, Bernreuter WK, Urist MM, Shumate CR, Maddox WA: Needle localization biopsy of the breast: impact of a selective core needle biopsy program on yield. Radiology 1995, 195:627-631.
4. Liberman L, Cohen MA, Dershaw, DD, Abramson AF, Hann LE, Rosen PP: Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. Am J Roentgenol 1995, 164:1111-1113. This study demonstrates the importance of performing a follow-up surgical biopsy after a diagnosis of atypical ductal hyperplasia is made at stereolaxic core breast biopsy, owing to the high prevalence of associated invasive and in situ ductal carcinoma.
5. Brenner RJ: Interventional procedures of the breast: medicolegal considerations. Radiology 1995, 195:611-615.
6. Morrow M: When can stereotactic core biopsy replace excisional biopsy? A clinical perspective. Breast Cancer Res Treat 1995, 36:1-9. A comprehensive review of the published literature evaluating the diagnostic accuracy of core biopsy for DCIS and invasive breast cancer and the ability of core biopsy to characterize malignant lesions sufficiently to allow treatment planning. Potential indications for the use of stereotactic core biopsy are given.
7. Howe JR, Monsees B, Destouet J, Seib J, Dehner LP, Kraybill WG: Needle localization breast biopsy: a model for multidisciplinary quality assurance. J Surg Oncol 1995, 58:233-239.
8. Goff JM, Molloy M, Debbas MT, Hale DA, Jaques DP: Long-term impact of previous breast biopsy on breast cancer screening modalities. J Surg Oncol 1995, 59:18-20.
9. Quiet CA, Ferguson DJ, Welchselbaum RR, Hellman S: Natural history of node-negative breast cancer: a study of 286 patients with long-term follow-up. J Clin Oncol 1995, 13:1144-1151. An extended follow-up evaluation of node-negative breast cancer patients treated with modified radical or radical mastectomy demonstrating the curability of breast cancer by local therapy alone, with size of tumor as the strongest predictor of dissemination and rate of relapse.
10. Mansfield CM, Komarnicky LT, Schwartz GF, Rosenberg AL, Krishnan L, Jewell WR, Rosato FE, Moses ML, Haghbin M, Taylor J: Ten-year results in 1,070 patients with stages I and II breast cancer treated by conservative surgery and radiation therapy. Cancer 1995, 9:2328-2336. A long-term evaluation of breast-conservation therapy with uniform treatment compared with reported series of similarly staged patients treated with mastectomy, demonstrating equivalent 10-year results. Local recurrence is discussed; however, the presence of DCIS or an extensive intraductal component was not evaluated.
11. Jacobson JA, Danforth DN, Cowan KH, Dangelo T, Steinberg SM, Pierce L, Lippman ME, Lichter AS, Glatstein E, Okunieff P: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 1995, 332:907-911. The 10-year results of a prospective randomized single-institution trial comparing lumpectomy, axillary dissection, and radiation with mastectomy and axillary dissection for stages I and II breast cancer. Equivalent survival statistics are confirmed, and prognostic factors for disease-free survival are indicated.
12. Rauschecker HF, Shauer R, Schauer A, Schumacher M, Olschewski, Sauerbrei W, Seegenschmiedt, Schmoor C: Therapy of small breast cancer: four-year results of a prospective non-randomized study. Breast Cancer Res Treat 1995, 34:1-13.
13. Solin LJ, Schultz DJ, Fowble BL: Ten-year results of the treatment of early-stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation, Int J Radiat Oncol Biol Phys 1995, 33:45-51. Emphasizes the similarity of breast cancer characteristics and outcome for elderly women compared with younger women (aged 50 to 64). Disease specific mortality for both groups was the same at 10 years; however, a significant difference was noted between the elderly and the younger group in mortality of intercurrent disease. This paper offers strong support for the continued use of standard breast-conserving surgery with definitive breast irradiation for appropriately selected elderly women with early stage breast carcinoma.
14. Recht A, Houlihan MJ: Conservative surgery without radiotherapy in the treatment of patients with early stage invasive breast cancer. Ann Surg 1995, 222:9-18. A definitive review addressing the question of whether some patients with early stage breast carcinoma can be adequately treated by conservative surgery alone without radiotherapy.
15. Craighead PS: Postoperative radiotherapy after conservative surgery in patients with early breast cancer. J Natl Cancer Inst 1995, 87:317-318.
16. Mokbel K, Ahmed M, Nash A, Sacks N: Reexcision operations in nonpalpable breast cancer. J Surg Oncol 1995, 58:225-228. A retrospective analysis of needle localization breast biopsy to determine the incidence of positive margins and whether significant residual disease can be identified in the reexcision specimens.
17. Silverstein MJ: The first chance is the best chance. J Surg Oncol 1995, 59:229-230.
18. Morrow M: Reexcision operations in nonpalpable breast cancer. J Surg Oncol 1995, 58:231-232.
19. D'Costa H, Barham CP, Jones PA, Teasdale C, Watkins RM: Simple method of orienting breast biopsies following hook-wire or ultrasonographic localization of impalpable mammographic abnormalities. Br J Surg 1995, 82:930.
20. Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR: The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995, 76:259-267. This study clearly demonstrates the impact of surgical margins on local control after breast-conserving treatment with lumpectomy and radiation therapy.
21. Connolly JL, Harris JR, Schnitt SJ: Understanding the distribution of cancer within the breast is important for optimizing breast-conserving treatment Cancer 1995, 76:1-3. An editorial that summarizes the evidence suggesting that the distribution of cancer, particularly in situ disease, plays a decisive role in local recurrence following breast-conserving treatment.
22. Holland R, Connolly J, Gelman R, et al.: The presence of an extensive intraductal component (EIC) following a limited excision correlates with prominent residual disease in the remainder of the breast J Clin Oncol 1990, 8:113-118.
23. Ohtake T, Abe R, Kimijima I, Fukushima T, Tsuchiya A, Hoshi K, Wakasa H: Intraductal extension of primary invasive breast carcinoma treated by breast conservative surgery: computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer 1995, 76:32-45. A detailed study depicting computer-generated three-dimensional graphic reconstructions of the duct-lobular systems demonstrating intraductal tumor extension. This paper offers significant objective support for a segmental theory of tumor spread, with implications for breast-conserving surgery.
24. Johnson JE, Page DL, Winfield AC, Reynolds VH, Sawyers JL: Recurrent mammary carcinoma after local excision: a segmental problem. Cancer 1995, 75:1612-1618. A review of the pathologic findings in five cases demonstrating a similarity in the recurrence pattern. Emphasis is placed on the presence of DCIS and its segmental distribution as major contributors to local recurrence.
25. Osteen RT: Strategies for breast-conserving surgery: an unresolved dilemma. Cancer 1995, 75:1563-1665.
26. Johnson JE, Page DL: Strategies for breast-conserving surgery: an unresolved dilemma-response. Cancer 1995, 75:1566-1567.
27. Page DL, Johnson JE: Controversies in the local management of invasive and noninvasive breast cancer. Cancer Lett 1995, 90:91-96. An excellent review of the current status of local management of breast cancer, with special emphasis on factors influencing the rate of local recurrence.
28. Haffty BG, Wilson LD, Smith R, Fischer D, Beinfield M, Ward B, Mckhann C: Subareolar breast cancer: Long-term results with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 1995, 33:53-57. An analysis of the subgroup of patients with central or subareolar breast tumors treated with breast conservation therapy, demonstrating similar survival statistics when compared with patients treated with breast conservation for cancers in noncentral breast locations.
29. Amichetti M, Busana L, Caffo O: Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer. Oncology 1995, 52:177-181.
30. Touboul E, Belkacemi Y, Lefranc JP, Uzan S, Ozsahin M, Korbas D, Buffat L, Balosso J, Pene F, Blondon J, Schlienger M, Laugier A: Early breast cancer: influence of type of boost (electrons vs. iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy. Radiother Oncol 1995, 34:105-113.
31. Van Lancker M, Goor C, Sacre R, Lamote J, Vanbelle S, Decoene N, Roelstraete A, Storme G: Patterns of axillary lymph node metastasis in breast cancer. Am J Clin Oncol 1995, 18:267-272.
32. Silverstein MJ, Gierson ED, Waisman JR, Colbum WJ, Gamagami P: Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995, 180:700-704. Demonstrates the superiority of a combination of T stage and palpability in predicting axillary nodal status versus T stage alone. Additionally, a significant percentage of positive nodes was noted in the T1 categories, underscoring the importance of axillary dissection in minimal breast cancer.
33. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S, Koyama H: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase polymerase chain reaction. Cancer 1994, 74:1595-1600.
34. Lehrer S, Garey J, Shank B: Nomograms for determining the probability of axillary node involvement in women with breast cancer. J Cancer Res Clin Oncol 1995, 121:123-125.
35. Menard S, Bufalino R, Rilke F, et al.: Prognosis based on primary breast carcinoma of pathological nodal status. Br J Cancer 1994, 70:709-712.
36. Menard S, Cascinelli N, Rilke F, Colnaghi MI: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1995, 87:607.
37. Ravdin PM, DeLaurentiis M, Vendely T, et al.: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1994, 86:1771-1775.
38. Ravdin PM, Clark GM: Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J Natl Cancer Inst 1995, 87:607-608.
39. Uren RF, Howman-Giles RB, Thompson JF, Malouf D, Ramsey-Stewart G, Niesche FW, Renwick SB: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995, 36:1775-1780. Demonstrates the ability of lymphoscintigraphy to define lymphatic drainage patterns for breast carcinoma.
40. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994, 220:391-401.
41. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995, 222:394-401. Sentinel lymph node dissection with a focused pathologic evaluation of the sentinel node was found to be more accurate in detecting nodal metastases than standard axillary lymph node dissection with routine histopathologic processing. The clinical impact of micrometastases in the overall prognosis in breast cancer patients is discussed.
42. Van Zyl JA, Muller AGS: Tumour excision plus continuous tamoxifen compared with modified radical mastectomy in patients over 70 years of age with operable breast cancer. J Surg 1995, 59:151-154.
43. Bergman L, Vandongen JA, Vanleeuwen FE: Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? Breast Cancer Res 1995, 34:77-83. A review of elderly patients who received tamoxifen as primary treatment demonstrating that this line of management produces a high risk of treatment failure and therefore should provide an acceptable alternative only for the elderly breast cancer patient who is unable to undergo surgery or radiotherapy.